Services

For pharma, biotech, medtech, diagnostics, and digital health companies, we offer an integrated pathway:

Clinical development → Market research → Commercial strategy → Regulatory approval → Pricing, HEOR, market access → Policy engagement → VBHC project management → Education, training, and stakeholder support.

We also help our clients shape the broader healthcare environment — supporting guideline development, payment model design, public health programs, and national health priorities.

We help clients and governments improve healthcare policy, financing, and delivery.

• Evidence generation to inform clinical guidelines, reimbursement, and policy
• Methodological support for national guideline development
• White papers, policy briefs, and technical reports
• Healthcare financing and payment reform
• Public health program evaluation and optimization
• Digital health evaluation, integration, and scale-up
• VBHC project design, pilot development, and management with payers, providers, and governments

We help companies build scientific leadership, credibility, and trust.

• KOL (Key Opinion Leader) identification and engagement
• Advisory boards, expert panels, and scientific boards
• Medical writing (protocols, publications, presentations)
• Scientific communication strategy and materials
• Medical affairs strategy and training
• Internal and external education programs

We equip clients with the knowledge to make informed, impactful decisions.

• Market research and feasibility studies
• Competitive landscape and patient journey mapping
• Provider, payer, patient insights
• Commercialization and launch strategy
• Value proposition development for products and solutions

We help clients navigate regulatory pathways and secure access for:

• Pharmaceuticals
• Medical devices
• In vitro diagnostics
• Digital health technologies

Our services include:

1. Regulatory strategy, dossier preparation, submission
2. Local adaptation of global registration files
3. Fast-track, orphan, and early access pathways
4. Health authority engagement and negotiation
5. Pricing strategy, cost-effectiveness, budget impact modeling
6. Reimbursement submissions and negotiation support
7. Value-based healthcare (VBHC) contracting and outcome-based payment models

We generate the data and insights that drive product development, approval, access, and system integration.

• Clinical trials (Phase I–III)
• Post-approval studies (Phase IV, RWE, registries, observational studies)
• Systematic reviews and meta-analyses
• Biostatistics, data management, advanced analytics
• Patient-reported outcomes (PRO), quality of life research
• Health economics and outcomes research (HEOR)
• Comparative effectiveness, benefit-risk analysis